The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12902-020-00633-1
PubMed Identifier: 33036588
Publication URI: http://europepmc.org/abstract/MED/33036588
Type: Journal Article/Review
Volume: 20
Parent Publication: BMC endocrine disorders
Issue: 1
ISSN: 1472-6823